Teva wins much-needed US approval of migraine drug

Teva Pharmaceutical on Friday secured a crucial U.S. approval for its preventive migraine treatment Ajovy, overcoming manufacturing problems at the drug's South Korean supplier which had threatened to further delay regulatory review.